Ultrasound in Medicine and Biology
Volume 36, Issue 10 , Pages 1626-1636 , October 2010

Perfusion CT and US of Colorectal Cancer Liver Metastases: A Correlative Study of Two Dynamic Imaging Modalities

  • Martijn R. Meijerink

      Affiliations

    • Department of Radiology, VU University Medical Center, Amsterdam, The Netherlands
    • Corresponding Author InformationAddress correspondence to: Martijn Ruben Meijerink, Department of Radiology, VU University Medical Center, De Boelelaan 1117, Postbus 7057, Amsterdam, The Netherlands.
    • ,
  • Jan Hein T.M. van Waesberghe

      Affiliations

    • Department of Radiology, VU University Medical Center, Amsterdam, The Netherlands
    • ,
  • Cors van Schaik

      Affiliations

    • Department of Radiology, VU University Medical Center, Amsterdam, The Netherlands
    • ,
  • Epie Boven

      Affiliations

    • Department of Medical Oncology, VU University Medical Center, Amsterdam, The Netherlands
    • ,
  • Astrid A.M. van der Veldt

      Affiliations

    • Department of Medical Oncology, VU University Medical Center, Amsterdam, The Netherlands
    • ,
  • Petrousjka van den Tol

      Affiliations

    • Department of Surgical Oncology, VU University Medical Center, Amsterdam, The Netherlands
    • ,
  • Sybren Meijer

      Affiliations

    • Department of Surgical Oncology, VU University Medical Center, Amsterdam, The Netherlands
    • ,
  • Cornelis van Kuijk

      Affiliations

    • Department of Radiology, VU University Medical Center, Amsterdam, The Netherlands

Received 29 September 2009 ,Revised 9 June 2010 ,Accepted 17 June 2010.

References 

  1. Bauer A, Solbiati L, Weissman N. Ultrasound imaging with SonoVue: Low mechanical index real-time imaging. Acad Radiol. 2002;9:282–284
  2. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet. 1986;8476:307–310
  3. Blomley MJ, Kormano M, Coulden R, Lim-Dunham J, Dawson P, Lipton MJ. Splenic blood flow: Evaluation with computed tomography. Acad Radiol. 1997;4:13–20
  4. Bonvalot S, Laplanche A, Lejeune F, Stoeckle E, Le Péchoux C, Vanel D, et al. Limb salvage with isolated perfusion for soft tissue sarcoma: Could less TNF-alpha be better?. Ann Oncol. 2005;16:1061–1068
  5. Byrt T. How good is that agreement?. Epidemiology. 1996;7:561
  6. Daldrup-Link HE, Simon GH, Brasch RC. Imaging of tumor angiogenesis: Current approaches and future prospects. Curr Pharm Des. 2006;12:2661–2672
  7. Eisenhauer EA, Therasse P, Bogaerts J, Schwartz LH, Sargent D, Ford R, et al. New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1). Eur J Cancer. 2009;45:228–247
  8. Elie N, Kaliski A, Péronneau P, Opolon P, Roche A, Lassau N. Methodology for quantifying interactions between perfusion evaluated by DCE-US and hypoxia throughout tumor growth. Ultrasound Med Biol. 2007;33:549–560
  9. Gillard JH, Antoun NM, Burnet NG, Pickard JD. Reproducibility of quantitative CT perfusion imaging. Br J Radiol. 2001;74:552–555
  10. Hotta N, Tagaya T, Maeno T, Ishikawa T, Okumura A, Fukuzawa Y, et al. Usefulness of contrast-enhanced ultrasonography with dynamic flow imaging to evaluate therapeutic effects for hepatocellular carcinoma. Hepatogastroenterology. 2003;50:1867–1871
  11. Hotta N, Tagaya T, Maeno T, Ayada M, Sato K, Ishikawa T, et al. Advanced dynamic flow imaging with contrast-enhanced ultrasonography for the evaluation of tumor vascularity in liver tumors. Clin Imaging. 2005;29:34–41
  12. ICRP. Publication 60 1990 Recommendations of the International Commission on Radiological Protection. Ann ICRP. 1991;31:1–3
  13. Jung EM, Clevert DA, Schreyer AG, Schmitt S, Rennert J, Kubale R, et al. Evaluation of quantitative contrast harmonic imaging to assess malignancy of liver tumors: A prospective controlled two-center study. World J Gastroenterol. 2007;13:6356–6364
  14. Krix M, Kiessling F, Essig M, Herth F, Karcher A, Le-Huu M, et al. Low mechanical index contrast-enhanced ultrasound better reflects high arterial perfusion of liver metastases than arterial phase computed tomography. Invest Radiol. 2004;39:216–222
  15. Krix M, Plathow C, Kiessling F, Herth F, Karcher A, Essig M, et al. Quantification of perfusion of liver tissue and metastases using a multivessel model for replenishment kinetics of ultrasound contrast agents. Ultrasound Med Biol. 2004;30:1355–1363
  16. Kruskal JB. Science to practice: Will improved assessment of response to antiangiogenic therapies be achieved with contrast-enhanced gray-scale US?. Radiology. 2006;240:1–2
  17. Lassau N, Mercier S, Koscielny S, Avril MF, Margulis A, Mamelle G, et al. Prognostic value of high-frequency sonography and color Doppler sonography for the preoperative assessment of melanomas. Am J Roentgenol. 1999;172:457–461
  18. Lassau N, Paturel-Asselin C, Guinebretiere JM, Leclère J, Koscielny S, Roche A, et al. New hemodynamic approach to angiogenesis: Color and pulsed Doppler ultrasonography. Invest Radiol. 1999;34:194–198
  19. Lassau N, Koscielny S, Opolon P, De Baere T, Peronneau P, Leclere J, et al. Evaluation of contrast-enhanced color Doppler ultrasound for the quantification of angiogenesis in vivo. Invest Radiol. 2001;36:50–55
  20. Lassau N, Koscielny S, Avril MF, Margulis A, Duvillard P, De Baere T, et al. Prognostic value of angiogenesis evaluated with high-frequency and color Doppler sonography for preoperative assessment of melanomas. AJR Am J Roentgenol. 2002;178:1547–1551
  21. Lassau N, Lamuraglia M, Chami L, Leclère J, Bonvalot S, Terrier P, et al. Gastrointestinal stromal tumors treated with imatinib: Monitoring response with contrast-enhanced sonography. Am J Roentgenol. 2006;187:1267–1273
  22. Lassau N, Chami L, Benatsou B, Peronneau P, Roche A. Dynamic contrast-enhanced ultrasonography (DCE-US) with quantification of tumor perfusion: A new diagnostic tool to evaluate the early effects of antiangiogenic treatment. Eur Radiol. 2007;17:89–98
  23. Lavisse S, Lejeune P, Rouffiac V, Elie N, Bribes E, Demers B, et al. Early quantitative evaluation of a tumor vasculature disruptive agent AVE8062 using dynamic contrast-enhanced ultrasonography. Invest Radiol. 2008;43:100–111
  24. Leggett DA, Kelley BB, Bunce IH, Miles KA. Colorectal cancer: Diagnostic potential of CT measurements of hepatic perfusion and implications for contrast enhancement protocols. Radiology. 1997;205:716–720
  25. Li J, Dong BW, Yu XL, Wang XH, Li CF. Time-intensity-based quantification of vascularity with single-level dynamic contrast-enhanced ultrasonography: A pilot animal study. J Ultrasound Med. 2005;24:975–983
  26. Lin L, Torbeck LD. Coefficient of accuracy and concordance correlation coefficient: New statistics for methods comparison. PDA J Pharm Sci Technol. 1998;52:55–59
  27. Marcus CD, Ladam-Marcus V, Cucu C, Bouché O, Lucas L, Hoeffel C. Crit. Imaging techniques to evaluate the response to treatment in oncology: Current standards and perspectives. Rev Oncol Hematol. 2008;(epub ahead of print)
  28. McCarville MB, Streck CJ, Dickson PV, Li CS, Nathwani AC, Davidoff AM. Angiogenesis inhibitors in a murine neuroblastoma model: Quantitative assessment of intratumoral blood flow with contrast-enhanced gray-scale US. Radiology. 2006;240:73–81
  29. Meijerink MR, van Cruijsen H, Hoekman K, Kater M, van Schaik C, van Waesberghe JH, et al. The use of perfusion CT for the evaluation of therapy combining AZD2171 with gefitinib in cancer patients. Eur Radiol. 2007;17:1700–1713
  30. Meijerink MR, van Waesberghe JH, van der Weide L, van den Tol P, Meijer S, van Kuijk C. Total-liver-volume perfusion CT using 3-D image fusion to improve detection and characterization of liver metastases. Eur Radiol. 2008;18:2345–2354
  31. Miles KA. Measurement of tissue perfusion by dynamic computed tomography. Br J Radiol. 1991;64:409–412
  32. Miles KA, Hayball M, Dixon AK. Colour perfusion imaging: A new application of computed tomography. Lancet. 1991;337:643–645
  33. Miles KA, Hayball MP, Dixon AK. Functional images of hepatic perfusion obtained with dynamic CT. Radiology. 1993;188:405–411
  34. Nagel HD. Radiation exposure in computed tomography: Fundamentals, influencing parameters, dose assessment, optimisation, scanner data, terminology. 2nd ed. Frankfurt, Germany: COCIR 2000; 69–72.
  35. Rouffiac V, Bouquet C, Lassau N, Opolon P, Koscielny S, Peronneau P, et al. Validation of a new method for quantifying in vivo murine tumor necrosis by sonography. Invest Radiol. 2004;39:350–356
  36. Sahani DV, Kalva SP, Hamberg LM, Hahn PF, Willett CG, Saini S, et al. Assessing tumor perfusion and treatment response in rectal cancer with multisection CT: Initial observations. Radiology. 2005;234:785–792
  37. Sessa C, Guibal A, Del Conte G, Rüegg C. Biomarkers of angiogenesis for the development of antiangiogenic therapies in oncology: Tools or decorations?. Nat Clin Pract Oncol. 2008;5:378–391
  38. Therasse P, Arbuck SG, Eisenhauer EA, Wanders J, Kaplan RS, Rubinstein L, et al. New guidelines to evaluate the response to treatment in solid tumors. J Natl Cancer Inst. 2000;205–216
  39. Tsushima Y, Funabasama S, Sanada S, Aoki J, Endo K. Development of perfusion CT software for personal computers. Acad Radiol. 2002;9:922–926
  40. Tsushima Y, Blomley MJ, Kusano S, Endo K. Measuring portal venous perfusion with contrast-enhanced CT: Comparison of direct and indirect methods. Acad Radiol. 2002;9:276–282
  41. Tsushima Y, Funabasama S, Aoki J, Sanada S, Endo K. Quantitative perfusion map of malignant liver tumors, created from dynamic computed tomography data. Acad Radiol. 2004;11:215–223
  42. Zhu AX, Holalkere NS, Muzikansky A, Horgan K, Sahani DV. Early antiangiogenic activity of bevacizumab evaluated by computed tomography perfusion scan in patients with advanced hepatocellular carcinoma. Oncologist. 2008;13:120–125

PII: S0301-5629(10)00306-6

doi: 10.1016/j.ultrasmedbio.2010.06.015

Ultrasound in Medicine and Biology
Volume 36, Issue 10 , Pages 1626-1636 , October 2010

Article Tools

* Image Usage & Resolution